| IMST | SHAM | P value |
---|---|---|---|
Anabolic steroids | Â | Â | Â |
   n (%) | 6 (17%) | 9 (26%) | 0.34 |
   Mean drug days | 10.8 ± 4.8 | 15.6 ± 7.3 | 0.19 |
Antibacterial agents | Â | Â | Â |
   n (%) | 30 (86%) | 29 (85%) | 0.77 |
   Mean drug days | 28. ± 27.8 | 31.0 ± 23.5 | 0.71 |
Antiviral agents | Â | Â | Â |
   n (%) | 3 (9%) | 1 (3%) | - |
   Mean drug days | 16.3 ± 4.0 | 6 | - |
Anti-arrhythmia agents | Â | Â | Â |
   n (%) | 13 (37%) | 9 (26%) | 0.34 |
   Mean drug days | 16.1 ± 11.0 | 14.8 ± 10.7 | 0.77 |
Anti-hypertensive agents | Â | Â | Â |
   n (%) | 17 (49%) | 20 (59%) | 0.47 |
   Mean drug days | 13.8 ± 11.7 | 15.3 ± 12.9 | 0.74 |
Bronchodilators | Â | Â | Â |
   n (%) | 16 (46%) | 20 (59%) | 0.28 |
   Mean drug days | 12.2 ± 7.5 | 17.3 ± 10.6 | 0.43 |
Corticosteroids | Â | Â | Â |
   n (%) | 16 (46%) | 13 (38%) | 0.53 |
   Mean drug days | 12.2 ± 7.5 | 10.8 ± 14.4 | 0.72 |
Diuretics | Â | Â | Â |
   n (%) | 21 (60%) | 23 (68%) | 0.47 |
   Mean drug days | 10.6 ± 6.6 | 11.0 ± 9.4 | 0.88 |
Anti-glycemic agents | Â | Â | Â |
   n (%) | 24 (69%) | 28 (82%) | 0.18 |
   Mean drug days | 13.5 ± 9.1 | 14.3 ± 11.1 | 0.77 |
Immune suppression agents | Â | Â | Â |
   n (%) | 3 (9%) | 3 (9%) | 0.70 |
   Mean drug days | 10.3 ± 14.4 | 3.7 ± 3.8 | 0.48 |
Neuromuscular blockers | Â | Â | Â |
   n (%) | 1 (3%) | 1 (3%) | - |
   Mean drug days | 2.0 | 2.0 | - |
Narcotic analgesic agents | Â | Â | Â |
   n (%) | 30 (86%) | 26 (76%) | 0.33 |
   Mean drug days | 12.4 ± 9.8 | 13.9 ± 8.7 | 0.55 |
Sedatives | Â | Â | Â |
   n (%) | 27 (77%) | 24 (71%) | 0.42 |
   Mean drug days | 13.4 ± 13.0 | 11.3 ± 9.1 | 0.50 |
Vasopressors | Â | Â | Â |
   n (%) | 5 (14%) | 8 (24%) | 0.33 |
   Mean drug days | 3.8 ± 4.7 | 3.1 ± 3.8 | 0.78 |
Beta-blockers | Â | Â | Â |
   n (%) | 31 (89%) | 29 (85%) | 0.96 |
   Mean drug days | 19.6 ± 20.9 | 22.0 ± 21.6 | 0.66 |